Nasdaq
KNSA
Kiniksa Pharmaceuticals International, plc
- Health Care
- Listed 2018
- 1 day
- −2.0%
- 1 month
- +13.7%
- 1 year
- +134%
$76.51 · Mkt cap $5.97B · P/E 102.01
At the 6 Aug 2026 close
Nasdaq
Kiniksa Pharmaceuticals International, plc
$76.51 · Mkt cap $5.97B · P/E 102.01
At the 6 Aug 2026 close
Kiniksa Pharmaceuticals International, plc trades under the ticker KNSA on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2018. Its market capitalisation is $5.97B. The last closing price was $76.51, on 6 Aug 2026. It trades at 102.01 times its last reported annual diluted earnings per share. Over the past year the share price is +134%, and +13.7% over the past month. Returns are price returns and exclude dividends.
This page exists because KNSA is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.